Franklin Covey Company FC
17.31
0.04
0.23%
as of 25 Sep
- Market cap
- $195.1M
- P/E
- 96.2×
Follow FC
| May '26 | Feb '26 | Nov '25 | Aug '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
134.22 | 0.00 | 0.00 | 78.36 |
+8 more quarters Free account |
P/S ratio |
1.04 | 0.56 | 0.74 | 0.95 | |
P/FCF ratio |
25.32 | 10.06 | 0.00 | 19.24 | |
P/Operating CF |
241.81 | 9.00 | 1,968.55 | 25.48 | |
P/B ratio |
6.34 | 3.85 | 3.57 | 3.78 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 222.14 | |
EV/Sales |
1.00 | 0.52 | 0.68 | 0.84 | |
EV/EBITDA |
13.05 | 10.02 | 12.65 | 11.66 | |
EV/Operating CF |
9.58 | 4.15 | 11.92 | 7.73 | |
EV/FCF |
24.44 | 9.29 | (80.72) | 17.02 | |
Quick Ratio |
0.44 | 0.42 | 0.52 | 0.64 | |
Current Ratio |
0.66 | 0.63 | 0.73 | 0.82 | |
Net Debt/EBITDA |
(1.55) | (10.24) | 40.85 | (2.77) | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
1.26 | 1.23 | 1.14 | 1.06 | |
Operating CF/Net income |
0.36 | (8.20) | (0.03) | 2.27 | |
Capex/Depreciation |
(0.61) | (0.93) | (1.16) | (2.15) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
63.80% | 72.92% | 72.01% | 61.98% | |
Intangible Assets out of Total Assets |
0.32 | 0.31 | 0.29 | 0.27 | |
Share Based Compensation of Revenue |
2.21% | 4.47% | 2.23% | 0.11% | |
Graham Net Nets |
(0.23) | (0.50) | (0.30) | (0.18) | |
Graham Number |
3.93 | 0.00 | 0.00 | 5.40 | |
Earnings Yield |
0.75% | (1.56%) | (0.70%) | 1.28% | |
Free Cash Flow Yield |
3.95% | 9.94% | (1.14%) | 5.20% | |
Revenue per Share |
6.02 | 5.22 | 5.25 | 5.51 | |
Operating CF per Share |
0.10 | 1.42 | 0.01 | 0.77 | |
Capex per Share |
(0.19) | (0.27) | (0.31) | (0.59) | |
Free Cash Flow per Share |
(0.09) | 1.15 | (0.30) | 0.18 | |
Cash per Share |
1.06 | 1.20 | 1.44 | 2.45 | |
Shareholders Equity per Share |
3.81 | 3.33 | 4.42 | 5.18 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
3.81 | 3.33 | 4.42 | 5.18 | |
Free Cash Flow |
(1.03) | 13.16 | (3.65) | 2.27 | |
Working Capital |
(48.32) | (56.81) | (39.71) | (27.81) | |
Capital Expenditures |
(2.15) | (3.10) | (3.75) | (7.67) | |
Net Current Asset Value |
(63.27) | (73.01) | (58.23) | (46.52) | |
EV/EBIT |
40.82 | 3,973.88 | 307.80 | 39.28 | |
Capex to Sales |
0.03 | 0.05 | 0.06 | 0.11 | |
Net Profit Margin |
4.55% | (3.32%) | (5.14%) | 6.14% | |
Price to Operating Income |
42.29 | 4,303.41 | 333.77 | 44.40 | |
| Other line items | |||||
Average Receivables |
50.06 | 51.74 | 60.28 | 77.21 | |
Average Payables |
6.33 | 6.70 | 5.75 | 8.32 | |
Average Inventory |
4.93 | 4.72 | 4.57 | 4.58 | |
Average Assets |
208.15 | 213.91 | 230.58 | 252.23 | |
Average Common Equity |
54.26 | 55.29 | 67.33 | 75.02 |
Columns are period end dates